FibroGen (FGEN) Misses Q1 EPS by 26c

FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.78), $0.26 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $16.3 million versus the consensus estimate of $34 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Liveworld, Inc. (LVWD) Reports In-Line Q2 EPS
• Fervo Energy Company (FRVO) Reports Q2 Loss of $0.38